Have a personal or library account? Click to login
Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism Cover

Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism

Open Access
|Jan 2024

References

  1. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358. https://doi.org/10.3390/ijms20092358 PMid:31085992
  2. Skowron F, Berard F, Balme B, Maucort-Boulch D. Role of obesity on the thickness of primary cutaneous melanoma. J Eur Acad Dermatol Venereol. 2015;29(2):262-9. https://doi.org/10.1111/jdv.12515 PMid:24750303
  3. Fang S, Wang Y, Dang Y, Gagel A, Ross MI, Gershenwald JE, et al. Association between body mass index, C-reactive protein levels, and melanoma patient outcomes. J Invest Dermatol. 2017;137(8):1792-5. https://doi.org/10.1016/j.jid.2017.04.007 PMid:28442307
  4. Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA. Obesity, inflammation, and cancer. Annu Rev Pathol. 2016;11:421-49. https://doi.org/10.1146/annurev-pathol-012615-044359 PMid:27193454
  5. Neagu M. Metabolic traits in cutaneous melanoma. Front Oncol. 2020;10:851. https://doi.org/10.3389/fonc.2020.00851 PMid:32509589
  6. Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and Type 2 diabetes. Front Physiol. 2020;10:1607. https://doi.org/10.3389/fphys.2019.01607 PMid:32063863
  7. Georgescu SR, Tampa M, Mitran CI, Mitran MI, Caruntu C, Caruntu A, et al. Tumour microenvironment in skin carcinogenesis. Adv Exp Med Biol. 2020;1226:123-42. https://doi.org/10.1007/978-3-030-36214-0_10 PMid:32030681
  8. Stanford KI, Middelbeek RJ, Townsend KL, Lee MY, Takahashi H, So K, et al. A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis. Diabetes. 2015;64(6):2002-14. https://doi.org/10.2337/db14-0704 PMid:25605808
  9. Saxena NK, Vertino PM, Anania FA, Sharma D. Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem. 2007;282(18):13316-25. https://doi.org/10.1074/jbc.M609798200 PMid:17344214
  10. Sooryanarain H, Heffron CL, Mahsoub HM, Hassebroek AM, Wang B, Tian D, et al. Modulation of SOCS3 levels via STAT3 and Estrogen-ERαp66 signaling during hepatitis E virus replication in hepatocellular carcinoma cells. J Virol. 2022;96(19):e0100822. https://doi.org/10.1128/jvi.01008-22 PMid:36102649
  11. Otero M, Lago R, Lago F, Reino JJ, Gualillo O. Signalling pathway involved in nitric oxide synthase Type II activation in chondrocytes: Synergistic effect of leptin with interleukin-1. Arthritis Res Ther. 2005;7(3):R581-91. https://doi.org/10.1186/ar1708 PMid:15899045
  12. Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, Päivärinta U, Moilanen T, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage-mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm. 2009;2009:345838. https://doi.org/10.1155/2009/345838 PMid:19688109
  13. Cassano S, Pucino V, La Rocca C, Procaccini C, De Rosa V, Marone G, et al. Leptin modulates autophagy in human CD4+CD25-conventional T cells. Metabolism. 2014;63(10):1272-9. https://doi.org/10.1016/j.metabol.2014.06.010 PMid:25060689
  14. Neagu M, Bostan M, Constantin C. Protein microarray technology: Assisting personalized medicine in oncology (Review). World Acad Sci J. 2019;1:113-24.
  15. Neagu M, Constantin C, Zurac S. Immune parameters in the prognosis and therapy monitoring of cutaneous melanoma patients: Experience, role, and limitations. Biomed Res Int. 2013;2013:107940. https://doi.org/10.1155/2013/107940 PMid:24163809
  16. Surcel M, Constantin C, Caruntu C, Zurac S, Neagu M. Inflammatory cytokine pattern is sex-dependent in mouse cutaneous melanoma experimental model. J Immunol Res. 2017;2017:9212134. https://doi.org/10.1155/2017/9212134 PMid:29318162
  17. Mikirova N, Riordan N, Casciari J. Modulation of cytokines in cancer patients by intravenous ascorbate therapy. Med Sci Monit. 2016;22:14-25. https://doi.org/10.12659/msm.895368 PMid:26724916
  18. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354(19):2034-45. https://doi.org/10.1056/NEJMra052706 PMid16687716
  19. Gouilleux F. Erythropoietin, thrombopoietin and leptin receptors. In: Goffin V, Kelly, PA, editors. Hormone Signaling. Endocrine Updates. Vol. 17. Boston, MA: Springer; 2002. https://doi.org/10.1007/978-1-4757-3600-7_8
  20. Matei C, Tampa M, Caruntu C, Ion RM, Georgescu SR, Dumitrascu GR, et al. Protein microarray for complex apoptosis monitoring of dysplastic oral keratinocytes in experimental photodynamic therapy. Biol Res. 2014;47(1):33. https://doi.org/10.1186/0717-6287-47-33 PMid:25204017
  21. Amjadi F, Mehdipoor R, Zarkesh-Esfahani H, Javanmard SH. Leptin serves as angiogenic/mitogenic factor in melanoma tumor growth. Adv Biomed Res. 2016;5:127. https://doi.org/10.4103/2277-9175.187005 PMid:27563637
  22. Oba J, Wei W, Gershenwald JE, Johnson MM, Wyatt CM, Ellerhorst JA, et al. Elevated serum leptin levels are associated with an increased risk of sentinel lymph node metastasis in cutaneous melanoma. Medicine (Baltimore). 2016;95(11):e3073. https://doi.org/10.1097/MD.0000000000003073 PMid:26986135
  23. Neagu M, Constantin C, Longo C. Chemokines in the melanoma metastasis biomarkers portrait. J Immunoassay Immunochem. 2015;36(6):559-66. https://doi.org/10.1080/15321819.2015.1035593 PMid:25839711
  24. Neagu M, Constantin C, Tanase C. Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma. Expert Rev Mol Diagn. 2010;10(7):897-919. https://doi.org/10.1586/erm.10.81 PMid:20964610
  25. Georgescu SR, Mitran CI, Mitran MI, Matei C, Constantin C, Neagu M, et al. Apprising diagnostic and prognostic biomarkers in cutaneous melanoma-persistent updating. J Pers Med. 2022;12(9):1506. https://doi.org/10.3390/jpm12091506 PMid:36143291
  26. Pisani A, Donno R, Valenti G, Pompa PP, Tirelli N, Bardi G. Chemokine-decorated nanoparticles target specific subpopulations of primary blood mononuclear leukocytes. Nanomaterials (Basel). 2022;12(20):3560. https://doi.org/10.3390/nano12203560 PMid:36296750
  27. Andjelkov K, Eremin II, Korac A. Different levels of EGF, VEGF, IL-6, MCP-1, MCP-3, IP-10, Eotaxin and MIP-1α in the adipose-derived stem cell secretome in androgenetic alopecia. Exp Dermatol. 2022;31(6):936-42. https://doi.org/10.1111/exd.14548 PMid:35226772
  28. Choi HJ, Jeon SY, Hong WK, Jung SE, Kang HJ, Kim JW, et al. Effect of glucose ingestion in plasma markers of inflammation and oxidative stress: Analysis of 16 plasma markers from oral glucose tolerance test samples of normal and diabetic patients. Diabetes Res Clin Pract. 2013;99(2):e27-31. https://doi.org/10.1016/j.diabres.2012.01.005 PMid:23410727
  29. Abshagen K, Mertens F, Eipel C, Vollmar B. Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers. Int J Clin Exp Pathol. 2013;6(9):1759-69. PMid:24040440
  30. de Candia P, Prattichizzo F, Garavelli S, Alviggi C, La Cava A, Matarese G. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J Exp Med. 2021;218(5):e20191593. https://doi.org/10.1084/jem.20191593 PMid:33857282
Language: English
Page range: 1 - 6
Submitted on: Feb 28, 2023
Accepted on: Apr 1, 2023
Published on: Jan 3, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Monica Neagu, Mihaela Surcel, Carolina Constantin, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.